Cargando…
Polysaccharides, Next Potential Agent for the Treatment of Epilepsy?
Epilepsy is a chronic neurological disorder. Current pharmacological therapies for epilepsy have limited efficacy that result in refractory epilepsy (RE). Owing to the limitations of conventional therapies, it is needed to develop new anti-epileptic drugs. The beneficial effects of polysaccharides f...
Autores principales: | Xie, Xuemin, Wu, Youliang, Xie, Haitao, Wang, Haiyan, Zhang, Xiaojing, Yu, Jiabin, Zhu, Shaofang, Zhao, Jing, Sui, Lisen, Li, Shaoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996301/ https://www.ncbi.nlm.nih.gov/pubmed/35418858 http://dx.doi.org/10.3389/fphar.2022.790136 |
Ejemplares similares
-
Next-Generation Sequencing in Korean Children With Autism Spectrum Disorder and Comorbid Epilepsy
por: Lee, Junghan, et al.
Publicado: (2020) -
Genetic Polymorphisms in Enzymes Involved in One-Carbon Metabolism and Anti-epileptic Drug Monotherapy on Homocysteine Metabolism in Patients With Epilepsy
por: Zhu, Shaofang, et al.
Publicado: (2021) -
Potentially Hazardous Drug-Drug Interactions Associated With Oral Antineoplastic Agents Prescribed in Chinese Tertiary Care Teaching Hospital Settings: A Multicenter Cross-Sectional Study
por: Wang, Haitao, et al.
Publicado: (2022) -
Brucea javanica oil alleviates intestinal mucosal injury induced by chemotherapeutic agent 5-fluorouracil in mice
por: Zheng, Xinghan, et al.
Publicado: (2023) -
Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step
por: Weiskirchen, Ralf
Publicado: (2016)